Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: Kessler Foundation
Multiple Sclerosis, Relapsing-Remitting
United States
Sponsor: Kessler Foundation
Multiple Sclerosis, Relapsing-Remitting
United States
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis · Primary Progressive Multiple Sclerosis
United States, Brazil, Czechia, Italy, New Zealand +3 more
Sponsor: Slb Pharma
Neurological Conditions · Brain Diseases · Cerebral Palsy · Parkinson Disease (PD)
France
Sponsor: University of California, San Francisco
Multiple Sclerosis · Clinically Isolated Syndrome · NMOSD · Myasthenia Gravis
United States
Sponsor: Washington University School of Medicine
Multiple Sclerosis (MS) - Relapsing-remitting
United States
Sponsor: Biogen
Multiple Sclerosis
United States, Australia, Germany, Ireland, Spain +2 more
- Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyActive Not Recruiting
Sponsor: Kuopio University Hospital
Neurodegenerative Diseases · Alzheimer Disease · Frontotemporal Dementia · Lewy Body Disease
Finland
- A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Bruce Cree
Progressive Multiple Sclerosis
United States
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of OfatumumabActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis (RMS)
United States, Puerto Rico
Sponsor: Sovargen
Focal Cortical Dysplasia · Tuberous Sclerosis Complex (TSC) · Hemimegalencephaly
Australia
- Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States, Australia, Austria, Brazil, Bulgaria +20 more
- Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisNot Yet Recruiting
Sponsor: Tongji Hospital
Multiple Sclerosis
China
- Autoimmune Intervention Mastery Course StudyActive Not Recruiting
Sponsor: Terry L. Wahls
Multiple Sclerosis · Clinically Isolated Syndrome · Fibromyalgia · Post Acute Sequelae of COVID-19
United States
Sponsor: University of Kansas Medical Center
Parkinson Disease · Multiple Sclerosis · Stroke
United States
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Multiple Sclerosis
Spain
- Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)Active Not Recruiting
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Multiple Sclerosis
Belgium, Czechia, Greece, Netherlands, Poland +1 more
- Objective Longitudinal Assessment of Postural Stability and Gait of Stroke, Parkinson's Disease and Multiple Sclerosis Using Instrumented Posturography and Three Dimensional Motion AnalysisEnrolling By Invitation
Sponsor: Somogy Megyei Kaposi Mór Teaching Hospital
Stroke · PARKINSON DISEASE (Disorder) · Multiple Sclerosis
Hungary
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States
Sponsor: University of Illinois at Chicago
Multiple Sclerosis
United States
- Acute Effects of Walking Exercise on Brain Functioning in Multiple SclerosisActive Not Recruiting
Sponsor: Kessler Foundation
Multiple Sclerosis
United States
- A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Brazil, France, Germany +4 more
- Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)Active Not Recruiting
Sponsor: Boston Children's Hospital
Tuberous Sclerosis · Autism Disorder · Intellectual Disability
United States
Sponsor: Coya Therapeutics
Amyotrophic Lateral Sclerosis (ALS)
United States, Canada
Sponsor: The University of Texas Health Science Center, Houston
Multiple Sclerosis
United States